Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
It is a lower-fee alternative to Ros $149 membership for patients who want FDA-approved medication without Ros full platform
His condition continues to deteriorate as he fights to get the frequency of his injections increased
See Individuals Tests See Individual Tests Test Code(s): 5193, 5194 Biomarkers Tested (55): Albumin ALBUMIN/GLOBULIN RATIO Alkaline Phosphatase ALT ALT (SGPT) AST AST (SGOT) Baso (Absolute) Basophils Bilirubin, Total BUN BUN/Creatinine Ratio Calcium Carbon Dioxide, Total Chloride Chol/HDLC Ratio Cholesterol, Total Creatinine eAG eGFR Eos Eos (Absolute) Estim
STORAGE Store at 28C, protected from light
Discontinuation due to adverse events was 16% in the 12 mg arm, higher than the roughly 7% discontinuation rate reported in SURMOUNT-1 for the highest tirzepatide dose [2]
How Payer Friction and Patient Drop-Off Undermine Obesity GLP-1 Uptake The GLP-1 market is experiencing unprecedented demand, yet despite its clinical promise for obesity, diabetes, and other conditions, patient behavior and friction throughout the treatment journey continue to erode its commercial potential
US$ 26.98
US$ 29.07
US$ 20.16
US$ 21.06
US$ 23.08
US$ 21.89
US$ 27.02
